These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2102626)

  • 21. High-resolution NMR studies of fibrinogen-like peptides in solution: structural basis for the bleeding disorder caused by a single mutation of Gly(12) to Val(12) in the A alpha chain of human fibrinogen Rouen.
    Ni F; Konishi Y; Bullock LD; Rivetna MN; Scheraga HA
    Biochemistry; 1989 Apr; 28(7):3106-19. PubMed ID: 2742828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Familial dysfibrinogenemia with abnormal nonomer aggregation. Paris III fibrinogen].
    Soria J; Soria C
    Pathol Biol (Paris); 1974 Nov; 22 suppl():72-9. PubMed ID: 4620099
    [No Abstract]   [Full Text] [Related]  

  • 23. A hereditary dysfibrinogenemia: fibrinogen Awaji.
    Matsuo T; Okuno S; Mukaida T; Ueshima S; Okada K; Matsuo O
    Haemostasis; 1987; 17(1-2):89-97. PubMed ID: 3596361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation of bound thrombin consisting of thrombin and fibrin N-terminal fragment from clot lysate.
    Kinjoh K; Nakamura M; Sunagawa M; Kosugi T
    Haematologia (Budap); 2002; 32(4):457-65. PubMed ID: 12803119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An A alpha Ser-434 to N-glycosylated Asn substitution in a dysfibrinogen, fibrinogen Caracas II, characterized by impaired fibrin gel formation.
    Maekawa H; Yamazumi K; Muramatsu S; Kaneko M; Hirata H; Takahashi N; de Bosch NB; Carvajal Z; Ojeda A; Arocha-Piñango CL
    J Biol Chem; 1991 Jun; 266(18):11575-81. PubMed ID: 1675636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg----His): fibrinogens Bergamo II, Essen and Perugia.
    Reber P; Furlan M; Henschen A; Kaudewitz H; Barbui T; Hilgard P; Nenci GG; Berrettini M; Beck EA
    Thromb Haemost; 1986 Dec; 56(3):401-6. PubMed ID: 3563970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrinogen Foxton: a novel BbetaA277V mutation causing low normal plasma fibrinogen concentration.
    Davis RL; Baker B; Brennan SO
    Thromb Haemost; 2008 Oct; 100(4):708-10. PubMed ID: 18841297
    [No Abstract]   [Full Text] [Related]  

  • 28. Genetically abnormal fibrinogens--strategies for structure elucidation, including fibrinopeptide analysis.
    Henschen A; Kehl M; Southan C
    Curr Probl Clin Biochem; 1984; 14():273-320. PubMed ID: 6391842
    [No Abstract]   [Full Text] [Related]  

  • 29. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
    Haverkate F; Koopman J; Kluft C; D'Angelo A; Cattaneo M; Mannucci PM
    Thromb Haemost; 1986 Feb; 55(1):131-5. PubMed ID: 3705000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An acquired abnormal fibrinogen associated with thromboembolic disease and pseudotumor cerebri.
    D'Souza L; Coots MC; Glueck HI
    Thromb Haemost; 1979 Oct; 42(3):994-1008. PubMed ID: 505412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Congenital dysfibrinogenemias. A review.
    Rocha E; Páramo JA; Aranda A; Cuesta B; Fernández J
    Ric Clin Lab; 1985; 15(3):205-29. PubMed ID: 3909359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A gamma methionine-310 to threonine substitution and consequent N-glycosylation at gamma asparagine-308 identified in a congenital dysfibrinogenemia associated with posttraumatic bleeding, fibrinogen Asahi.
    Yamazumi K; Shimura K; Terukina S; Takahashi N; Matsuda M
    J Clin Invest; 1989 May; 83(5):1590-7. PubMed ID: 2496144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Electrofocusing of abnormal fibrinogens in polyacrylamide gel].
    Soria J; Soria C; Durand G; Feger J
    Ann Biol Clin (Paris); 1972; 30(2):161-5. PubMed ID: 5040625
    [No Abstract]   [Full Text] [Related]  

  • 34. Fibrinogen Bergamo III and fibrinogen Torino: two further variants with hereditary molecular defects in fibrinopeptide A.
    Reber P; Furlan M; Beck EA; Barbui T
    Thromb Res; 1987 Apr; 46(1):163-7. PubMed ID: 3590111
    [No Abstract]   [Full Text] [Related]  

  • 35. High-performance liquid chromatography of proteins as applied to fibrinogen chains.
    Kehl M; Lottspeich F; Henschen A
    Hoppe Seylers Z Physiol Chem; 1982 Dec; 363(12):1501-5. PubMed ID: 7160829
    [No Abstract]   [Full Text] [Related]  

  • 36. Dysfibrinogenemia associated with liver disease.
    Palascak JE; Martinez J
    J Clin Invest; 1977 Jul; 60(1):89-95. PubMed ID: 874092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydrodynamic characterization of recombinant human fibrinogen species.
    Raynal B; Cardinali B; Grimbergen J; Profumo A; Lord ST; England P; Rocco M
    Thromb Res; 2013 Jul; 132(1):e48-53. PubMed ID: 23642654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategy for recombinant multichain protein synthesis: fibrinogen B beta-chain variants as thrombin substrates.
    Lord ST; Strickland E; Jayjock E
    Biochemistry; 1996 Feb; 35(7):2342-8. PubMed ID: 8652575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The broad diversity of neutral and sialylated oligosaccharides derived from human salivary mucins.
    Klein A; Carnoy C; Wieruszeski JM; Strecker G; Strang AM; van Halbeek H; Roussel P; Lamblin G
    Biochemistry; 1992 Jul; 31(26):6152-65. PubMed ID: 1627559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localization of a fibrin gamma-chain polymerization site within segment Thr-374 to Glu-396 of human fibrinogen.
    Horwitz BH; Váradi A; Scheraga HA
    Proc Natl Acad Sci U S A; 1984 Oct; 81(19):5980-4. PubMed ID: 6592597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.